MCID: STR008
MIFTS: 50

Strongyloidiasis malady

Rare diseases, Infectious diseases, Gastrointestinal diseases categories

Aliases & Classifications for Strongyloidiasis

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 2CDC, 65UMLS, 36MeSH, 29ICD9CM, 59SNOMED-CT, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet, 27ICD10
See all sources

Aliases & Descriptions for Strongyloidiasis:

Name: Strongyloidiasis 10 45 47 12 51 2 65 36
Disseminated Strongyloidiasis 10 65
Anguilluliasis 51 65
Infection by Strongyloides 10
 
Threadworm Infection 45
Anguillulosis 51
Enterobiasis 65


Classifications:



Characteristics (Orphanet epidemiological data):

51
strongyloidiasis:
Inheritance: Not applicable; Age of onset: All ages


External Ids:

Disease Ontology10 DOID:10955
ICD9CM29 127.2
MeSH36 D013322
Orphanet51 76
ICD10 via Orphanet28 B78.0, B78.1, B78.7 B78.9, more
MESH via Orphanet37 D013322
UMLS via Orphanet66 C0038463
ICD1027 B78, B78.7, B78.9

Summaries for Strongyloidiasis

About this section
NIH Rare Diseases:45 Strongyloidiasis is a parasitic disease caused by the roundworm strongyloides stercoralis (s. stercoralis). people catch the infection when they come in contact with soil contaminated with the worms. while there are often no symptoms, abdominal pain, cough, diarrhea, rash, unintentional weight loss and vomiting may occur. the infection is treated with anti-worm medications such as ivermectin. strongyloidiasis is found in tropical and subtropical areas, but can also be found in temperate regions, including the southern united states. last updated: 9/20/2010

MalaCards based summary: Strongyloidiasis, also known as disseminated strongyloidiasis, is related to colitis and opisthorchiasis. An important gene associated with Strongyloidiasis is IL5 (Interleukin 5), and among its related pathways are Inflammatory Response Pathway and IL-15 Signaling and its Primary Biological Effects in Different Immune Cell Types. The drugs ivermectin and thiabendazole have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and lung, and related mouse phenotypes are respiratory system and hematopoietic system.

Disease Ontology:10 A parasitic helminthiasis infectious disease that involves infection of the intestine, lungs, skin and central nervous system with nematode strongyloides stercoralis.

CDC:2 Strongyloidiasis was first described in French troops stationed in modern day Vietnam during the late 19th century who were suffering from severe, persistent diarrhea. It is a parasitic disease caused by nematodes, or roundworms, in the genus Strongyloides that enter the body through exposed skin, such as bare feet. Strongyloides is most common in tropical or subtropical climates.

Wikipedia:68 Strongyloidiasis is a human parasitic disease caused by the nematode (roundworm) called Strongyloides... more...

Related Diseases for Strongyloidiasis

About this section

Diseases related to Strongyloidiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 194)
idRelated DiseaseScoreTop Affiliating Genes
1colitis30.5CD79A, IFNG
2opisthorchiasis29.9CD79A, IFNG, TGFB1
3asthma28.8CCL11, CD79A, IFNG, IL13, IL5, TGFB1
4eosinophilia10.5
5meningitis10.4
6duodenitis10.4
7nephrotic syndrome10.4
8schistosomiasis10.4
9systemic lupus erythematosus10.3
10lupus erythematosus10.3
11leukemia10.3
12acquired immunodeficiency syndrome10.3
13purpura10.3
14adult t-cell leukemia10.3
15paralytic ileus10.3
16t-cell leukemia10.3
17mechanical entropion10.2CD79A, IL5
18appendicitis10.2
19anthrax disease10.2CD79A, IL5
20common variable immunodeficiency10.2
21glomerulonephritis10.2
22membranoproliferative glomerulonephritis10.2
23filariasis10.2
24parasitic helminthiasis infectious disease10.2
25rhabditida infections10.2
26secernentea infections10.2
27pemphigus and fogo selvagem10.2CCL11, IL5
28anal paget's disease10.2CD79A, TGFB1
29chronic myeloproliferative disease10.2CCL11, IL5
30bursitis10.2CD79A, IL5
31broad ligament malignant neoplasm10.2CD79A, TGFB1
32barre-lieou syndrome10.2CCL11, IL5
33thalamic neoplasm10.2CCL11, IL5
34loeffler syndrome10.2CCL11, IL5
35ocular melanoma10.2CD79A, TGFB1
36pancreatic endocrine carcinoma10.2CCL11, CD79A
37eosinophilic mastitis10.1IFNG, IL5
38esophagitis10.1CCL11, IL5
39silo filler's disease10.1CCL11, IL5
40scleroderma10.1IFNG, IL5
41limbic encephalitis with ncmags antibodies10.1IFNG, IL5
42iritis10.1CD79A, IFNG
43choroid epithelioid cell melanoma10.1CCL11, CD79A
44acute conjunctivitis10.1CD79A, IFNG
45multicentric osteolysis nephropathy10.1IFNG, IL5
46hughes-stovin syndrome10.1IFNG, IL5
47chronic hiccups10.1CD79A, IFNG
48dermatomycosis10.1CCL11, CD79A
49microsporidiosis10.1CD79A, IFNG
50trichuriasis10.1

Graphical network of the top 20 diseases related to Strongyloidiasis:



Diseases related to strongyloidiasis

Symptoms for Strongyloidiasis

About this section

Drugs & Therapeutics for Strongyloidiasis

About this section

Drugs for Strongyloidiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
IvermectinapprovedPhase 34570288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
HMS2089M09
I 8898
 
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
Sklice
Soolantra
Stromectol
2
AlbendazoleapprovedPhase 36854965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
3AnthelminticsPhase 3363
4
Piperazineapproved21110-85-04837
Synonyms:
1,4-Diazacyclohexane
1,4-Diethylenediamine
1,4-Piperazine
110-85-0
14007-05-7 (unspecified hydrobromide)
142-63-2 (hexahydrate)
142-64-3 (di-hydrochloride)
14538-56-8 (phosphate[1:1])
16832-43-2 (unspecified hydrate)
1951-97-9 (unspecified phosphate)
3597-26-0 (unspecified sulfate)
5-23-01-00030 (Beilstein Handbook Reference)
6094-40-2 (unspecified hydrochloride)
7542-23-6 (mono-hydrochloride)
8017-90-1
8027-81-4
8057-14-5 (unspecified salt)
80621_FLUKA
854880-15-2
861800-35-3
AB1003720
AC1L1J2E
AC1Q1IA7
AC1Q1IA8
AC1Q1IA9
AKOS000269028
AR-1L1009
ARONIS23910
Anthalazine
Antiren
Asca-Trol No. 3
BIDD:GT0273
BRN 0102555
C07973
CCRIS 5950
CHEBI:28568
CHEMBL1412
CID4837
D00807
DB00592
Diethylenediamine
Diethyleneimine
Dispermine
DivK1c_000038
EINECS 203-808-3
Eraverm
Eraverm (VAN)
Fluphenazine dihydrochloride
HMS1920H20
HMS2092A03
HMS500B20
HSDB 1093
Hexahydro-1,4-diazine
Hexahydropyrazine
I14-11172
IDI1_000038
InChI=1/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H
Jsp000824
KBio1_000038
KBio2_001593
KBio2_004161
KBio2_006729
KBioSS_001593
LS-517
LTBB000432
Lumbrical
MolPort-000-872-010
NCGC00094762-01
NCGC00094762-02
NCIOpen2_000984
NCIOpen2_000988
NCIOpen2_001024
NCIOpen2_001031
NCIOpen2_001033
NCIOpen2_001071
NCIOpen2_001073
 
NCIOpen2_001111
NCIOpen2_001151
NCIOpen2_001231
NCIOpen2_001262
NCIOpen2_001269
NCIOpen2_004830
NCIOpen2_004834
NCIOpen2_004862
NCIOpen2_004874
NCIOpen2_004904
NCIOpen2_004910
NCIOpen2_004914
NCIOpen2_004942
NCIOpen2_004952
NCIOpen2_004954
NCIOpen2_004982
NCIOpen2_004992
NCIOpen2_004994
NCIOpen2_005022
NCIOpen2_005032
NCIOpen2_005034
NCIOpen2_005062
NCIOpen2_005072
NCIOpen2_005102
NCIOpen2_005108
NCIOpen2_005145
NCIOpen2_005182
NCIOpen2_005185
NCIOpen2_005187
NCIOpen2_005200
NCIOpen2_005575
NCIOpen2_005980
NCIOpen2_009422
NINDS_000038
NSC 474
NSC474
P0446
P0447
P45907_SIAL
PIPERAZINE (HEXAHYDRATE)
PZE
Piperazidine
Piperazin
Piperazin [German]
Piperazin [Germany]
Piperazine
Piperazine (USP)
Piperazine Dihydrochloride Dihydrochloride Hydrate
Piperazine Hexa-Hydrate
Piperazine [UN2579] [Corrosive]
Piperazine [UN2579] [Corrosive]
Piperazine [USAN]
Piperazine anhydrous
Piperazine citrate
Piperazine hexahydrate
Piperazine hydrate
Piperazine, anhydrous
Pipersol
Pyrazine hexahydride
Pyrazine, hexahy
SPECTRUM1500490
Spectrum5_001817
Spectrum_001113
UN2579
UNII-1RTM4PAL0V
Upixon
Uvilon
Vermex
Vermizine
Vermizine (TN)
Vermizine (tn)
WLN: T6M DMTJ
Worm-A-Ton
Worm-away
Wurmirazin
nchembio814-comp12
piperazine
piperazinium oleate
5
Mebendazoleapproved2131431-39-74030
Synonyms:
(5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
(5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Benzoyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI)
31431-39-7
46404_FLUKA
46404_RIEDEL
5-Benzoyl-2-benzimidazolecarbamic acid methyl ester
5-Benzoyl-2-benzimidazolecarbamic acid, methyl ester
AB00052203
AC-12064
AC1L1H98
AC1Q44DR
AKOS000539066
Abello Farmacia Brand of Mebendazole
Anti Worm
Anti-Worm
Ardeypharm Brand of Mebendazole
BAS 00341140
BIDD:GT0087
BPBio1_000257
BRD-K77987382-001-01-7
BRD-K77987382-001-06-6
BSPBio_000233
BSPBio_003178
Bantenol
Banworm
Besantin
Bio-0458
Bio-0803
Boots Brand of Mebendazole
Boots Threadworm Treatment
CAS-31431-39-7
CBDivE_010559
CCRIS 4479
CHEBI:6704
CHEMBL685
CID4030
CPD000036734
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester (9CI)
Carbamic acid, N-(5-benzoylbenzimidazol-2-yl)-, methyl ester
D00368
D008463
DB00643
Degort's Brand of Mebendazole
Diba Brand of Mebendazole
DivK1c_000751
EINECS 250-635-4
Elfar Brand of Mebendazole
Equivurm Plus
Esteve Brand of Mebendazole
HMS1536H11
HMS1568L15
HMS1921F03
HMS2090B03
HMS2092B15
HMS502F13
HSDB 3232
Healthypharm Brand of Mebendazole
I06-2075
IDI1_000751
Janssen Brand of Mebendazole
KBio1_000751
KBio2_001778
KBio2_004346
KBio2_006914
KBio3_002398
KBioGR_000712
KBioSS_001778
LS-48951
Leidapharm Brand of Mebendazole
Lomper
M2523_FLUKA
M2523_SIGMA
MBDZ
MEBENDAZOLE, 99%
MLS000028491
Madicure
Mebendan
Mebendazol
Mebendazol [INN-Spanish]
Mebendazole
Mebendazole (JAN/USP)
 
Mebendazole (JAN/USP/INN)
Mebendazole [USAN:INN:BAN:JAN]
Mebendazole(USAN)
Mebendazolum
Mebendazolum [INN-Latin]
Mebenoazole
Mebenvet
Mebex
Mebutar
Methyl 5-benzoyl benzimidazole-2-carbamate
Methyl 5-benzoyl-2-benzimidazolecarbamate
Methyl 5-benzoyl-2-benzimidazolylcarbamate
Methyl N-(5-benzoyl-1H-benzimidazol-2-yl)carbamate
Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate
MolPort-000-765-625
MolPort-001-889-615
Mébendazole
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle [French]
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle [French]
NCGC00016806-01
NCGC00016806-02
NCGC00021698-03
NCGC00021698-04
NCGC00021698-05
NCGC00021698-06
NINDS_000751
NSC 184849
NSC184849
Norgine Brand of Mebendazole
Noverme
Oprea1_278237
Oprea1_768530
Ovitelmin
Pantelmin
Pfizer Brand of Mebendazole
Prestwick0_000217
Prestwick1_000217
Prestwick2_000217
Prestwick3_000217
Prestwick_310
Pripsen Mebendazole
Probes1_000013
Probes2_000149
R 17,635
R 17635
R-17635
R17635
SAM002548959
SMR000036734
SPBio_001442
SPBio_002154
SPECTRUM1501110
SSL Brand of Mebendazole
STK093862
Spectrum2_001401
Spectrum3_001439
Spectrum4_000416
Spectrum5_001381
Spectrum_001298
Sqworm
Streger Brand of Mebendazole
Sufil
Surfont
TL8002405
Taxandria Brand of Mebendazole
Tedec Meiji Brand of Mebendazole
Telmin
TimTec1_000869
UNII-81G6I5V05I
Vermicidin
Vermicol
Vermidil
Vermin
Vermirax
Vermox
Vermox (TN)
Verpanyl
Versid
Wormkuur
ZINC00121541
mebendazole
methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl [5-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate
6
Formaldehydeexperimental6550-00-0712
Synonyms:
Aldeide formica
Fannoform
Formaldehyde
Formalina
Formaline
Formalith
Formic aldehyde
Formol
 
Methaldehyde
Methanal
Methyl aldehyde
Methylene glycol
Methylene oxide
Oxomethane
Oxomethylene
Oxymethylene
Paraform
Paraformaldehyde
7Piperazine citrate21
8Ether49

Interventional clinical trials:

idNameStatusNCT IDPhase
1Multiple Versus Single Dose of Ivermectin for the Treatment of StrongyloidiasisRecruitingNCT01570504Phase 3
2Ivermectin Versus Albendazole for Chronic StrongyloidiasisEnrolling by invitationNCT00765024Phase 3
3Study of Patients With Strongyloides Stercoralis InfectionCompletedNCT00001245
4Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm InfectionsCompletedNCT00207753
5The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon IslandsCompletedNCT01080989
6Management of Soil-transmitted Helminthiasis and StrongyloidiasisRecruitingNCT01308268
7Parasitic Infections of the Gastrointestinal TractRecruitingNCT00001162
8Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive DisordersActive, not recruitingNCT02105714

Search NIH Clinical Center for Strongyloidiasis

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: Strongyloidiasis

Genetic Tests for Strongyloidiasis

About this section

Anatomical Context for Strongyloidiasis

About this section

MalaCards organs/tissues related to Strongyloidiasis:

33
Skin, Testes, Lung, T cells, Kidney, Colon, Liver

Animal Models for Strongyloidiasis or affiliated genes

About this section

MGI Mouse Phenotypes related to Strongyloidiasis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053887.6CCL11, IFNG, IL13, IL5, TGFB1
2MP:00053977.3CCL11, CD79A, IFNG, IL13, IL5, TGFB1
3MP:00053877.0CCL11, CD79A, IFNG, IL13, IL5, TGFB1

Publications for Strongyloidiasis

About this section

Articles related to Strongyloidiasis:

(show top 50)    (show all 544)
idTitleAuthorsYear
1
Megaduodenum associated with gastric strongyloidiasis. (25951613)
2015
2
Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy. (25925183)
2015
3
Update on immunologic and molecular diagnosis of human strongyloidiasis. (24686097)
2014
4
Strongyloidiasis hyperinfection in a patient with a history of systemic lupus erythematosus. (25092815)
2014
5
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. (23592987)
2013
6
Strongyloidiasis presenting as larva currens 38 years after presumed exposure. (23149200)
2012
7
Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin. (22975175)
2012
8
A series on intestinal strongyloidiasis in immunocompetent and immunocompromised hosts. (23025061)
2012
9
IgG avidity in differential serodiagnosis of human strongyloidiasis active infection. (21699917)
2011
10
Uncomplicated strongyloidiasis in a liver transplant recipient on steroid-free immunosuppression. (20487417)
2010
11
Pulmonary strongyloidiasis. (20329418)
2009
12
Identification of a 26-kDa protein fraction as an important antigen for application in the immunodiagnosis of strongyloidiasis. (17569087)
2007
13
IgG1, IgG4, and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract as heterologous antigen. (17610082)
2007
14
Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-up. (17135451)
2007
15
Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma. (17641892)
2007
16
Strongyloidiasis stercoralis: is it a health problem in Saudi Arabia? (17366869)
2006
17
Intestinal strongyloidiasis and common variable immunodeficiency syndrome. (15876606)
2005
18
Cutaneous periumbilical purpura in disseminated strongyloidiasis in cancer patients: a pathognomonic feature of potentially lethal disease? (16410894)
2005
19
Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock. (16041520)
2005
20
Severe gastrointestinal strongyloidiasis. (16082494)
2005
21
Successful ivermectin treatment of hepatic strongyloidiasis presenting with severe eosinophilia. (15455986)
2004
22
Pulmonary strongyloidiasis presenting as chronic bronchitis leading to interlobular septal fibrosis and cured by treatment. (14708557)
2003
23
Strongyloides venezuelensis alkaline extract for the diagnosis of human strongyloidiasis by enzyme-linked immunosorbent assay. (14595467)
2003
24
Strongyloidiasis and natural killer cell lymphocytosis. (10809888)
2000
25
Pulmonary strongyloidiasis--case report of 2 cases. (10969524)
2000
26
High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. (11042682)
2000
27
Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies). (10096585)
1999
28
Strongyloidiasis, angio-oedema and natural killer cell lymphocytosis. (10354098)
1999
29
Parasite-specific serum IgG following successful treatment of endemic strongyloidiasis using ivermectin. (9015524)
1996
30
Fulminant, systemic strongyloidiasis in AIDS. (8758145)
1996
31
Expression of CD23, CD32, Mac-1 and other adhesion molecules in eosinophils in strongyloidiasis and HTLV-I-positive patients. (8906113)
1996
32
Interrelation of strongyloidiasis and tuberculosis. (8063205)
1994
33
Strongyloides stercoralis: the first rodent model for uncomplicated and hyperinfective strongyloidiasis, the Mongolian gerbil (Meriones unguiculatus). (8245532)
1993
34
Fatal adult respiratory distress syndrome following successful treatment of pulmonary strongyloidiasis. (1995245)
1991
35
Aphthoid ulceration of the colon in strongyloidiasis. (2028960)
1991
36
Gelatin particle indirect agglutination test for mass examination for strongyloidiasis. (1755062)
1991
37
Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area. (2588581)
1989
38
Diagnosis of pulmonary strongyloidiasis by bronchoalveolar lavage. (3409752)
1988
39
Endemic institutional strongyloidiasis in British Columbia. (3607675)
1987
40
Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. (2886441)
1987
41
Seroepidemiology of strongyloidiasis in a Thai village. (3429125)
1987
42
Concentrations of thiabendazole and parasite-specific IgG antibodies in the cerebrospinal fluid of a patient with disseminated strongyloidiasis. (3611836)
1987
43
Indigenous strongyloidiasis in Nottingham. (3109595)
1987
44
Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. (3711300)
1986
45
Risk factors for strongyloidiasis. A case-control study. (6696569)
1984
46
Cambendazole in the treatment of human strongyloidiasis. (6625071)
1983
47
Immunological features in different clinical forms of strongyloidiasis. (6623593)
1983
48
Pulmonary strongyloidiasis. (7063915)
1982
49
Strongyloidiasis and chronic urticaria. (7111108)
1982
50
Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. (7026811)
1981

Variations for Strongyloidiasis

About this section

Expression for genes affiliated with Strongyloidiasis

About this section
Search GEO for disease gene expression data for Strongyloidiasis.

Pathways for genes affiliated with Strongyloidiasis

About this section

Pathways related to Strongyloidiasis according to GeneCards Suite gene sharing:

(show all 16)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.5IFNG, IL5
2
Show member pathways
9.4IFNG, TGFB1
39.4IFNG, TGFB1
49.4IFNG, TGFB1
5
Show member pathways
8.9CD79A, IL13, IL5
68.8IL13, IL5, TGFB1
7
Show member pathways
8.7IFNG, IL13, IL5
8
Show member pathways
8.7IFNG, IL13, IL5
98.7IFNG, IL13, IL5
108.7IFNG, IL13, IL5
11
B cell receptor signaling pathway (KEGG)
Show member pathways
8.6IFNG, IL13, IL5
128.6IFNG, IL13, TGFB1
138.2IFNG, IL13, IL5, TGFB1
14
Show member pathways
7.7CCL11, IFNG, IL13, IL5, TGFB1
15
Show member pathways
7.7CCL11, IFNG, IL13, IL5, TGFB1
16
Show member pathways
7.7CCL11, IFNG, IL13, IL5, TGFB1

GO Terms for genes affiliated with Strongyloidiasis

About this section

Cellular components related to Strongyloidiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.1CD79A, IFNG, IL13
2extracellular spaceGO:00056157.7CCL11, IFNG, IL13, IL5, TGFB1
3extracellular regionGO:00055767.4CCL11, IFNG, IL13, IL5, TGFB1

Biological processes related to Strongyloidiasis according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of interleukin-17 productionGO:003270010.0IFNG, TGFB1
2protein import into nucleus, translocationGO:000006010.0IFNG, TGFB1
3extrinsic apoptotic signaling pathwayGO:009719110.0IFNG, TGFB1
4positive regulation of protein secretionGO:00507149.7IL13, TGFB1
5positive regulation of B cell proliferationGO:00308909.7IL13, IL5
6response to radiationGO:00093149.5CCL11, TGFB1
7neutrophil chemotaxisGO:00305939.3CCL11, IFNG
8inflammatory responseGO:00069548.4CCL11, IL13, IL5, TGFB1
9immune responseGO:00069557.8CCL11, IFNG, IL13, IL5

Molecular functions related to Strongyloidiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051258.2IFNG, IL13, IL5, TGFB1

Sources for Strongyloidiasis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet